1. Cell Biology
  2. Immunology and Inflammation

RNA N6-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice

  1. Bochuan Li
  2. Ting Zhang
  3. Mengxia Liu
  4. Zhen Cui
  5. Yanhong Zhang
  6. Mingming Liu
  7. Yanan Liu
  8. Yongqiao Sun
  9. Mengqi Li
  10. Yikui Tian
  11. Ying Yang  Is a corresponding author
  12. Hongfeng Jiang  Is a corresponding author
  13. Degang Liang  Is a corresponding author
  1. Tianjin Medical University, China
  2. Chinese Academy of Sciences, China
  3. Capital Medical University, China
https://doi.org/10.7554/eLife.69906
Share this article
Cite this article
  1. Bochuan Li
  2. Ting Zhang
  3. Mengxia Liu
  4. Zhen Cui
  5. Yanhong Zhang
  6. Mingming Liu
  7. Yanan Liu
  8. Yongqiao Sun
  9. Mengqi Li
  10. Yikui Tian
  11. Ying Yang
  12. Hongfeng Jiang
  13. Degang Liang
(2022)
RNA N6-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice
eLife 11:e69906.
https://doi.org/10.7554/eLife.69906
  2. Download BibTeX
  3. Download .RIS

Abstract

Atherosclerosis preferentially occurs in atheroprone vasculature where human umbilical vein endothelial cells (HUVECs) are exposed to disturbed flow. Disturbed flow is associated with vascular inflammation and focal distribution. Recent studies have revealed the involvement of epigenetic regulation in atherosclerosis progression. N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic mRNA, but its function in endothelial atherogenic progression remains unclear. Here, we show that m6A mediates the EGFR signaling pathway during EC activation to regulate the atherosclerotic process. Oscillatory stress (OS) reduced the expression of METTL3, the primary m6A methyltransferase. Through m6A sequencing and functional studies, we determined that m6A mediates the mRNA decay of the vascular pathophysiology gene EGFR which leads to EC dysfunction. m6A modification of the EGFR 3'UTR accelerated its mRNA degradation. Double mutation of the EGFR 3'UTR abolished METTL3-induced luciferase activity. Adenovirus-mediated METTL3 overexpression significantly reduced EGFR activation and endothelial dysfunction in the presence of OS. Furthermore, TSP-1, an EGFR ligand, was specifically expressed in atheroprone regions without being affected by METTL3. Inhibition of the TSP-1/EGFR axis by using shRNA and AG1478 significantly ameliorated atherogenesis. Overall, our study revealed that METTL3 alleviates endothelial atherogenic progression through m6A-dependent stabilization of EGFR mRNA, highlighting the important role of RNA transcriptomics in atherosclerosis regulation.

Data availability

RNA-seq and MeRIP-seq data generated in this study have been deposited to the Genome Sequence Archive in BIG Data Center under accession number PRJCA004746.

The following data sets were generated

Article and author information

Author details

  1. Bochuan Li

    Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  2. Ting Zhang

    CAS Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Mengxia Liu

    CAS Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Zhen Cui

    Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Yanhong Zhang

    Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  6. Mingming Liu

    Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  7. Yanan Liu

    Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  8. Yongqiao Sun

    CAS Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  9. Mengqi Li

    Tianjin Medical University General Hospital Cardiovascular Department, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  10. Yikui Tian

    Tianjin Medical University General Hospital Cardiovascular Department, Tianjin Medical University, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.

  11. Ying Yang

    CAS Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, Beijing, China
    For correspondence
    yingyang@big.ac.cn
    Competing interests
    The authors declare that no competing interests exist.

  12. Hongfeng Jiang

    Key Laboratory of Remodeling-Related Cardiovascular Diseases, Capital Medical University, Tianjin, China
    For correspondence
    jhf@pku.edu.cn
    Competing interests
    The authors declare that no competing interests exist.

  13. Degang Liang

    Tianjin Medical University General Hospital Cardiovascular Department, Tianjin Medical University, Tianjin, China
    For correspondence
    15922230066@163.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2618-6651

Funding

National Natural Science Foundation of China (81900396)

  • Bochuan Li

National Natural Science Foundation of China (82000477)

  • Mengqi Li

National Natural Science Foundation of China (81970392)

  • Hongfeng Jiang

Postdoctoral Research Foundation of China (2019M661041)

  • Bochuan Li

Postdoctoral Research Foundation of China (BX20190235)

  • Bochuan Li

China Association for Science and Technology (Excellent Sino-foreign Youth Exchange Program)

  • Bochuan Li

National Natural Science Foundation of China (91940304)

  • Ying Yang

Chinese Academy of Sciences (2018133)

  • Ying Yang

National Key Research and Development Program of China (2018YFA0801200)

  • Ying Yang

Beijing Nova Program (Z201100006820104)

  • Ying Yang

National Natural Science Foundation of China (81870207)

  • Yikui Tian

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Edward A Fisher, New York University Grossman School of Medicine, United States

Ethics

Animal experimentation: The investigation conformed to the Guide for the Care and Use of Laboratory Animals by the US National Institutes of Health (NIH 17 Publication No. 85-23, revised in 2011). All study protocols and the use of animals were approved by the Institutional Animal Care and Use Committee of Tianjin Medical University.

Version history

  1. Received: April 29, 2021
  2. Accepted: January 7, 2022
  3. Accepted Manuscript published: January 10, 2022 (version 1)
  4. Version of Record published: January 27, 2022 (version 2)

Copyright

© 2022, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 976
    views
  • 168
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bochuan Li
  2. Ting Zhang
  3. Mengxia Liu
  4. Zhen Cui
  5. Yanhong Zhang
  6. Mingming Liu
  7. Yanan Liu
  8. Yongqiao Sun
  9. Mengqi Li
  10. Yikui Tian
  11. Ying Yang
  12. Hongfeng Jiang
  13. Degang Liang
(2022)
RNA N6-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice
eLife 11:e69906.
https://doi.org/10.7554/eLife.69906

Share this article

https://doi.org/10.7554/eLife.69906

Categories and tags

Research organism

Further reading

    1. Cancer Biology
    2. Cell Biology

    A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo

    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology

    Cancer: Modeling glioblastoma

    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.

    1. Cell Biology
    2. Neuroscience

    Presynaptic Rac1 in the hippocampus selectively regulates working memory

    Jaebin Kim, Edwin Bustamante ... Scott H Soderling
    Research Article

    One of the most extensively studied members of the Ras superfamily of small GTPases, Rac1 is an intracellular signal transducer that remodels actin and phosphorylation signaling networks. Previous studies have shown that Rac1-mediated signaling is associated with hippocampal-dependent working memory and longer-term forms of learning and memory and that Rac1 can modulate forms of both pre- and postsynaptic plasticity. How these different cognitive functions and forms of plasticity mediated by Rac1 are linked, however, is unclear. Here, we show that spatial working memory in mice is selectively impaired following the expression of a genetically encoded Rac1 inhibitor at presynaptic terminals, while longer-term cognitive processes are affected by Rac1 inhibition at postsynaptic sites. To investigate the regulatory mechanisms of this presynaptic process, we leveraged new advances in mass spectrometry to identify the proteomic and post-translational landscape of presynaptic Rac1 signaling. We identified serine/threonine kinases and phosphorylated cytoskeletal signaling and synaptic vesicle proteins enriched with active Rac1. The phosphorylated sites in these proteins are at positions likely to have regulatory effects on synaptic vesicles. Consistent with this, we also report changes in the distribution and morphology of synaptic vesicles and in postsynaptic ultrastructure following presynaptic Rac1 inhibition. Overall, this study reveals a previously unrecognized presynaptic role of Rac1 signaling in cognitive processes and provides insights into its potential regulatory mechanisms.